Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
Q2 2025 vs. Q1 2025
How the institutions holding Virpax Pharmaceuticals, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 7 | 1 | −6 |
| Shares | 29.1K | 9 | −29.1K (−100.0%) |
| Value | $34.9K | $2 | −$34.9K (−100.0%) |
New holders (0)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
None.
Sold out (6)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Millennium Management LLC | 22,075 | $26.5K |
| Tower Research Capital LLC (TRC) | 4,897 | $5.88K |
| UBS Group AG | 2,000 | $2.40K |
| SBI Securities Co., Ltd. | 108 | $130 |
| Bank of America Corp | 5 | $6 |
| Vermillion Wealth Management, Inc. | 4 | $5 |